ocrelizumab
roche
['ocrelizumab']
prospective, real-world use of ocrelizumab in paediatric-onset ms: highly effective in reducing arr, but no significant changes in bicams. #aanam 
Neurologist, specialist in multiple sclerosis and related disorders